Jesse Goodman

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Signature
/s/ Jesse Goodman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jesse Goodman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. Director Common Stock 19.5K $642K $32.99 Jun 12, 2024 Direct
BiomX Inc. Director Common Stock Options - Right to Buy 264K Jul 11, 2024 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11.5K Jun 12, 2024 Direct

Insider Reports Filed by Jesse Goodman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHGE BiomX Inc. Jul 11, 2024 1 $0 4 Jul 15, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
PHGE BiomX Inc. Mar 15, 2024 0 $0 3 Mar 21, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
NTLA Intellia Therapeutics, Inc. Jun 23, 2021 2 $0 4 Jun 25, 2021 Director